Several studies have attested to the higher prevalence of triple negative tumours with poorer prognosis in breast cancer patients of African origin [5, 11], although a study from Nigeria reported no difference in the pattern of hormone receptors in the African breast cancer population compared to other populations [12]. Here, NR4A1 is linked to breast carcinoma.